Evidence map›Paper›PMID 24475132›Full record

ArticlePloS one2014

Diverse metastable structures formed by small oligomers of α-synuclein probed by force spectroscopy.

Krishna Neupane, Allison Solanki, Iveta Sosova, Miro Belov, Michael T Woodside

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Unfolded and intermediate states of PrP play a key role in the mechanism of action of an antiprion chaperone.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Size and topology modulate the effects of frustration in protein folding.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Krishna NeupaneDepartment of Physics, University of Alberta, Edmonton, Alberta, Canada.
Allison SolankiDepartment of Physics, University of Alberta, Edmonton, Alberta, Canada.
Iveta SosovaNational Institute for Nanotechnology, National Research Council Canada, Edmonton, Alberta, Canada.
Miro BelovNational Institute for Nanotechnology, National Research Council Canada, Edmonton, Alberta, Canada.
Michael T WoodsideDepartment of Physics, University of Alberta, Edmonton, Alberta, Canada ; National Institute for Nanotechnology, National Research Council Canada, Edmonton, Alberta, Canada.

Funding

Canadian Institutes of Health Research NHG 91374
6 · The paper itself

Abstract

Oligomeric aggregates are widely suspected as toxic agents in diseases caused by protein aggregation, yet they remain poorly characterized, partly because they are challenging to isolate from a heterogeneous mixture of species. We developed an assay for characterizing structure, stability, and kinetics of individual oligomers at high resolution and sensitivity using single-molecule force spectroscopy, and applied it to observe the formation of transient structured aggregates within single oligomers of α-synuclein, an intrinsically-disordered protein linked to Parkinson's disease. Measurements of the molecular extension as the proteins unfolded under tension in optical tweezers revealed that even small oligomers could form numerous metastable structures, with a surprisingly broad range of sizes. Comparing the structures formed in monomers, dimers and tetramers, we found that the average mechanical stability increased with oligomer size. Most structures formed within a minute, with size-dependent rates. These results provide a new window onto the complex α-synuclein aggregation landscape, characterizing the microscopic structural heterogeneity and kinetics of different pathways.

Indexed as

Protein Structure, Quaternaryalpha-SynucleinEscherichia coliGene ExpressionHumansKineticsOptical TweezersProtein AggregatesProtein EngineeringProtein UnfoldingRecombinant ProteinsSpectrum AnalysisThermodynamicsalpha-SynucleinProtein AggregatesRecombinant Proteins

Identifiers

PMID24475132
PMCPMC3901707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.